Reflector-guided localization compared with wire-guided localization for non-palpable breast cancer resection: organizational impacts and costs analysis.

Autor: Cavagna P; Pharmacy Department, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, 20 Rue Leblanc, Paris 75015, France., Martin T; Pharmacy Department, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, 20 Rue Leblanc, Paris 75015, France; Université Paris-Saclay, GRADES, Faculty of Pharmacy, 17 Av. des Sciences, Orsay 91400, France., Martelli N; Pharmacy Department, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, 20 Rue Leblanc, Paris 75015, France; Université Paris-Saclay, GRADES, Faculty of Pharmacy, 17 Av. des Sciences, Orsay 91400, France., Nguyen-Xuan HT; Université Paris Cité, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Gynecological Oncology Surgery Department, 20 Rue Leblanc, Paris 75015, France., Henri A; Université Paris Cité, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Gynecological Oncology Surgery Department, 20 Rue Leblanc, Paris 75015, France; Centre de Recherche des Cordeliers, « Equipe labélisée Ligue Contre le Cancer », CNRS SNC 5096, Sorbonne Université, Université de Paris Cité, INSERM, Paris, France., Benoit L; Université Paris Cité, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Gynecological Oncology Surgery Department, 20 Rue Leblanc, Paris 75015, France; Environmental Toxicity, Therapeutic Targets, Cellular Signaling and Biomarkers, T3S, INSERM UMR-S 1124, Paris F-75006, France. Electronic address: louise.am.benoit@gmail.com., Bentivegna E; Université Paris Cité, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Gynecological Oncology Surgery Department, 20 Rue Leblanc, Paris 75015, France., Bats AS; Université Paris Cité, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Gynecological Oncology Surgery Department, 20 Rue Leblanc, Paris 75015, France; Centre de Recherche des Cordeliers, « Equipe labélisée Ligue Contre le Cancer », CNRS SNC 5096, Sorbonne Université, Université de Paris Cité, INSERM, Paris, France., Koual M; Université Paris Cité, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Gynecological Oncology Surgery Department, 20 Rue Leblanc, Paris 75015, France; Environmental Toxicity, Therapeutic Targets, Cellular Signaling and Biomarkers, T3S, INSERM UMR-S 1124, Paris F-75006, France.
Jazyk: angličtina
Zdroj: Journal of gynecology obstetrics and human reproduction [J Gynecol Obstet Hum Reprod] 2024 Dec 06; Vol. 54 (2), pp. 102892. Date of Electronic Publication: 2024 Dec 06.
DOI: 10.1016/j.jogoh.2024.102892
Abstrakt: Background: Wire-guided localization (WGL) for non-palpable breast cancer lesions has drawbacks like wire migration, localization difficulties, and logistical challenges. Wireless methods, such as reflector-guided localization (RGL), address these issues and are compatible with breast MRI. This study evaluates the organizational and cost impacts of RGL compared to WGL.
Research Design and Methods: Our retrospective study compared the organizational impacts and costs of RGL and WGL at a university hospital. Quantitative and qualitative assessments included operating time and a questionnaire for surgeons and radiologists. Cost analysis covered device costs.
Results: The study involved 60 patients (30 with RGL and 30 with WGL). The RGL group had a significantly longer duration between device insertion and surgery (3.73 ± 5.5 days) compared to the WGL group (same day or day before surgery). The WGL group required more devices whereas cost were higher for RGL. Health professionals reported a major positive impact of RGL on healthcare processes and safety, with minor negative impact on training.
Conclusions: RGL offers flexible scheduling by decoupling radiology and surgery but is limited by high costs. Further data is needed to identify ideal candidates, assess patient satisfaction, and evaluate its long-term benefits in breast cancer care.
Competing Interests: Declaration of competing interest None.
(Copyright © 2024 Elsevier Masson SAS. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: